{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:10:01Z","timestamp":1792455001859,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.vaccine.2016.04.035","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T02:29:57Z","timestamp":1461983397000},"page":"2692-2699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Development and characterization of a new carrier for vaccine delivery based on calcium-alginate nanoparticles: Safe immunoprotective approach against scorpion envenoming"],"prefix":"10.1016","volume":"34","author":[{"given":"Faez Amokrane","family":"Nait Mohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Laraba-Djebari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.vaccine.2016.04.035_bib0210","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1021\/js9602812","article-title":"Controlled delivery of antigens and adjuvants in vaccine development","volume":"85","author":"Zhao","year":"1996","journal-title":"J Pharm Sci"},{"issue":"12","key":"10.1016\/j.vaccine.2016.04.035_bib0215","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1139\/y03-115","article-title":"Effect of gamma irradiation on toxicity and immunogenicity of Androctonus australis hector venom","volume":"81","author":"Abib","year":"2003","journal-title":"Can J Physiol Pharmacol"},{"issue":"1","key":"10.1016\/j.vaccine.2016.04.035_bib0220","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/08923970701812324","article-title":"Irradiated Cerastes cerastes venom as a novel tool for immunotherapy","volume":"30","author":"Oussedik-Oumehdi","year":"2008","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"11","key":"10.1016\/j.vaccine.2016.04.035_bib0225","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/15058","article-title":"Advances in vaccine adjuvants","volume":"17","author":"Singh","year":"1999","journal-title":"Nat Biotechnol"},{"issue":"48","key":"10.1016\/j.vaccine.2016.04.035_bib0230","doi-asserted-by":"crossref","first-page":"8951","DOI":"10.1016\/j.vaccine.2011.09.044","article-title":"Enhanced immune sera and vaccine: safe approach to treat scorpion envenoming","volume":"29","author":"Lila","year":"2011","journal-title":"Vaccine"},{"issue":"47","key":"10.1016\/j.vaccine.2016.04.035_bib0235","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1016\/j.vaccine.2012.08.023","article-title":"Nanovaccinology: the next generation of vaccines meets 21st century materials science and engineering","volume":"30","author":"Mamo","year":"2012","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2016.04.035_bib0240","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jconrel.2004.06.003","article-title":"Micellar carriers based on block copolymers of poly(epsilon-caprolactone) and poly(ethylene glycol) for doxorubicin delivery","volume":"98","author":"Shuai","year":"2004","journal-title":"J Control Release"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2016.04.035_bib0245","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijpharm.2008.01.030","article-title":"Sustained release of antineoplastic drugs from chitosan-reinforced alginate microparticle drug delivery systems","volume":"357","author":"Yu","year":"2008","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.vaccine.2016.04.035_bib0250","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3748\/wjg.v5.i1.57","article-title":"Preparation and distribution of 5-fluorouracil (125)I sodium alginate-bovine serum albumin nanoparticles","volume":"5","author":"Yi","year":"1999","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.vaccine.2016.04.035_bib0255","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0169-409X(02)00044-3","article-title":"Nanoparticles in cancer therapy and diagnosis","volume":"54","author":"Brigger","year":"2002","journal-title":"Adv Drug Deliv Rev"},{"issue":"15","key":"10.1016\/j.vaccine.2016.04.035_bib0260","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.addr.2008.08.002","article-title":"Hydrogel nanoparticles in drug delivery","volume":"60","author":"Hamidi","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2016.04.035_bib0265","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijpharm.2009.10.018","article-title":"Polymer-based nanocapsules for drug delivery","volume":"385","author":"Mora-Huertas","year":"2010","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.vaccine.2016.04.035_bib0270","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0169-409X(00)00116-2","article-title":"Nanoparticulate systems for the delivery of antisense oligonucleotides","volume":"47","author":"Lambert","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2016.04.035_bib0275","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cis.2014.03.009","article-title":"Preparation methods of alginate nanoparticles","volume":"209","author":"Paques","year":"2014","journal-title":"Adv Colloid Interface Sci"},{"issue":"36","key":"10.1016\/j.vaccine.2016.04.035_bib0280","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1016\/j.vaccine.2012.06.021","article-title":"Advax, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses","volume":"30","author":"Honda-Okubo","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2016.04.035_bib0285","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ejpb.2008.01.019","article-title":"Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles","volume":"69","author":"Borges","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"10.1016\/j.vaccine.2016.04.035_bib0290","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1021\/mp200264m","article-title":"Chitosan microparticles and nanoparticles as biocompatible delivery vehicles for peptide and protein-based immunocontraceptive vaccines","volume":"9","author":"Chua","year":"2012","journal-title":"Mol Pharm"},{"issue":"4\u20135","key":"10.1016\/j.vaccine.2016.04.035_bib0295","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejps.2007.08.005","article-title":"Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles","volume":"32","author":"Borges","year":"2007","journal-title":"Eur J Pharm Sci"},{"issue":"12","key":"10.1016\/j.vaccine.2016.04.035_bib0300","doi-asserted-by":"crossref","first-page":"pe53314","DOI":"10.1371\/journal.pone.0053314","article-title":"Preparation and efficacy of a live newcastle disease virus vaccine encapsulated in chitosan nanoparticles","volume":"7","author":"Zhao","year":"2012","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.vaccine.2016.04.035_bib0305","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12250-012-3269-2","article-title":"An effective mannosylated chitosan nanoparticle DNA vaccine for FMD virus","volume":"27","author":"Nanda","year":"2012","journal-title":"Virol Sin"},{"issue":"52","key":"10.1016\/j.vaccine.2016.04.035_bib0310","doi-asserted-by":"crossref","first-page":"32835","DOI":"10.1016\/S0021-9258(20)30067-3","article-title":"The kaliotoxin family enlarged, purification, characterization, and precursor nucleotide sequence of KTX2 from Androctonus australis venom","volume":"269","author":"Laraba-Djebari","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2016.04.035_bib0315","first-page":"254","article-title":"Use of toxic fraction isolated from Algerian Androctonus australis hector scorpion venom for the assessment of anti-venom serum","volume":"62","author":"Laraba-Djebari","year":"1998","journal-title":"Arch Inst Pasteur Alger"},{"issue":"43","key":"10.1016\/j.vaccine.2016.04.035_bib0320","doi-asserted-by":"crossref","first-page":"5756","DOI":"10.1016\/j.vaccine.2015.09.045","article-title":"Enhancement of long-lasting immunoprotective effect against Androctonus australis hector envenomation using safe antigens: comparative role of MF59 and Alum adjuvants","volume":"33","author":"Nouri","year":"2015","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2016.04.035_bib0325","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/jps.2600820909","article-title":"Development of a new drug carrier made from alginate","volume":"82","author":"Rajaonarivony","year":"1993","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1016\/j.vaccine.2016.04.035_bib0330","doi-asserted-by":"crossref","first-page":"442","DOI":"10.4103\/0250-474X.119829","article-title":"Alginate nanoparticles as a promising adjuvant and vaccine delivery system","volume":"75","author":"Sarei","year":"2013","journal-title":"Indian J Pharm Sci"},{"key":"10.1016\/j.vaccine.2016.04.035_bib0335","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"issue":"4","key":"10.1016\/j.vaccine.2016.04.035_bib0340","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1034\/j.1600-079X.2003.00085.x","article-title":"Melatonin protects against pro-oxidant enzymes and reduces lipid peroxidation in distinct membranes induced by the hydroxyl and ascorbyl radicals and by peroxynitrite","volume":"35","author":"Teixeira","year":"2003","journal-title":"J Pineal Res"},{"issue":"10","key":"10.1016\/j.vaccine.2016.04.035_bib0345","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.4049\/jimmunol.142.10.3518","article-title":"Stimulation of degranulation from human eosinophils by platelet-activating factor","volume":"142","author":"Kroegel","year":"1989","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2016.04.035_bib0350","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1586\/14760584.2.2.269","article-title":"Microparticles as vaccine adjuvants and delivery systems","volume":"2","author":"O\u2019Hagan","year":"2003","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"10.1016\/j.vaccine.2016.04.035_bib0355","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/btpr.10","article-title":"Biomaterials as vaccine adjuvants","volume":"24","author":"Jones","year":"2008","journal-title":"Biotechnol Prog"},{"issue":"25","key":"10.1016\/j.vaccine.2016.04.035_bib0360","first-page":"4926","article-title":"Protein nanoparticle: a unique system as drug delivery vehicles","volume":"7","author":"Jahanshahi","year":"2008","journal-title":"Afr J Biotechnol"},{"issue":"8","key":"10.1016\/j.vaccine.2016.04.035_bib0365","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nnano.2007.223","article-title":"Immunological properties of engineered nanomaterials","volume":"2","author":"Dobrovolskaia","year":"2007","journal-title":"Nat Nanotechnol"},{"issue":"4","key":"10.1016\/j.vaccine.2016.04.035_bib0370","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.nantod.2014.06.001","article-title":"Nanotoxoid vaccines","volume":"9","author":"Hu","year":"2014","journal-title":"Nano Today"},{"issue":"6","key":"10.1016\/j.vaccine.2016.04.035_bib0375","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00701-012-1302-8","article-title":"Methothrexate attenuates early neutrophil infiltration and the associated lipid peroxidation in the injured spinal cord but does not induce neurotoxicity in the uninjured spinal cord in rats","volume":"154","author":"Sanli","year":"2012","journal-title":"Acta Neurochir (Wien)"},{"issue":"4","key":"10.1016\/j.vaccine.2016.04.035_bib0380","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0306-4522(97)00011-0","article-title":"Role of neutrophils in spinal cord injury in the rat","volume":"79","author":"Taoka","year":"1997","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.vaccine.2016.04.035_bib0385","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nnano.2009.175","article-title":"Evaluation of nanoparticle immunotoxicity","volume":"4","author":"Dobrovolskaia","year":"2009","journal-title":"Nat Nanotechnol"},{"issue":"2","key":"10.1016\/j.vaccine.2016.04.035_bib0390","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1210\/en.2009-1082","article-title":"Nanoparticles and the immune system","volume":"151","author":"Zolnik","year":"2010","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.vaccine.2016.04.035_bib0395","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1517\/17425240802600662","article-title":"Alginate-based sustained release drug delivery systems for tuberculosis","volume":"5","author":"Ahmad","year":"2008","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"10.1016\/j.vaccine.2016.04.035_bib0400","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2217\/nnm.11.169","article-title":"Interaction of nanoparticles with immunocompetent cells: nanosafety considerations","volume":"7","author":"Boraschi","year":"2012","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.vaccine.2016.04.035_bib0405","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.carbpol.2015.01.028","article-title":"The supramolecular structure of LPS\u2013chitosan complexes of varied composition in relation to their biological activity","volume":"123","author":"Davydova","year":"2015","journal-title":"Carbohydr Polym"},{"issue":"1","key":"10.1016\/j.vaccine.2016.04.035_bib0410","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/adhm.201200268","article-title":"Micro and nanoparticle-based delivery systems for vaccine immunotherapy: an immunological and materials perspective","volume":"2","author":"Leleux","year":"2013","journal-title":"Adv Healthc Mater"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16301761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16301761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T03:48:56Z","timestamp":1718509736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16301761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":41,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0264410X16301761"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.04.035","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and characterization of a new carrier for vaccine delivery based on calcium-alginate nanoparticles: Safe immunoprotective approach against scorpion envenoming","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.04.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}